Request For Proposals – Supply of Rituximab, Infliximab and Tocilizumab

Pharmac invites proposals for the supply of rituximab, infliximab and tocilizumab in New Zealand.

This request for proposals (RFP) letter incorporates the following schedules:

• Schedule 1 specifies the pharmaceuticals for which Pharmac is requesting proposals and sets out the background to the RFP and the types of proposals sought;
• Schedule 2 describes the process that Pharmac expects to follow in relation to the RFP;
• Schedule 3 sets out information about the estimated size of the current subsidised market and estimated forecasted market for the pharmaceuticals;
• Attachment 1 is the form in which you can provide non-price information;
• Attachment 2 is the form in which you can provide price information;
• Attachment 3 contains Pharmac’s standard terms and conditions for supply of pharmaceuticals;
• Attachment 4 contains the standard Principal Supply Status terms; 
• Attachment 5 is the New Zealand Government Supplier Code of Conduct.